Navigation Links
Novan Awarded $7.8 Million Contract by BARDA to Develop a Medical Countermeasure for Thermal Burns
Date:8/26/2013

DURHAM, N.C., Aug. 26, 2013 /PRNewswire/ -- Novan Therapeutics announced today that the U.S. Department of Health and Human Services has entered into a contract with Novan to advance the development of a nitric oxide-based therapy as a topical treatment for thermal burns.  The Biomedical Advanced Research and Development Authority (BARDA), an agency within the Office of the Assistant Secretary for Preparedness and Response, awarded this contract.  It is widely believed a mass casualty event caused by natural or intentional threats to public health could result in tens of thousands of burn patients which would overwhelm the burn care infrastructure presently available in hospitals across the United States. 

(Logo: http://photos.prnewswire.com/prnh/20130228/NE68367LOGO )

Under the terms of the contract, BARDA will provide funding of $7.8 million over two years.  The contract will support the pharmaceutical development of the Nitric Oxide Advanced Healing (NOAH) technology including formulation work, nonclinical toxicology, and proof of concept studies in models of deep partial thickness and full thickness thermal injuries.  This project is designed to enable the future clinical investigation of the medical countermeasure.

"We are honored that BARDA selected our team to develop a nitric oxide therapy for thermal burns," said Nathan Stasko, president of Novan.  Nitric oxide, a molecule produced by the human body, has been demonstrated throughout peer-reviewed literature to speed the migration of epidermal cells, stimulate new blood vessel growth, modulate inflammation, and re-model the wound bed.  Dr. Stasko continued, "The link between nitric oxide and the body's ability to heal is well established.  The challenge is to create stable nitric oxide drugs that 'perform on com
'/>"/>

SOURCE Novan Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novan Announces Promising Results of SB204 Clinical Study
2. Novans SB204 Could Be First Topical Sebum Inhibitor
3. Fountain Valley Regional Medical Center Becomes Orange Countys First Hospital Awarded Advanced Certification In Inpatient Diabetes Care
4. aTyr Pharma Awarded Two Patents from USPTO to Support Development of New Therapeutics Based on Physiocrine Biology
5. Arisaph Pharmaceuticals Awarded Phase I STTR Grant To Develop Small Molecule Immune Modulators
6. All Time Medical awarded a Google Trusted Store badge.
7. Dynamic Healthcare Services Awarded Two Oxygen Equipment Competitive Bidding Contracts
8. Instrumentation Laboratory Awarded Premier Healthcare Alliance Contract For Hemostasis Product Line
9. Great Lakes NeuroTechnologies Awarded Patent For Technology To Treat Parkinsons Disease With Brain Stimulation During Sleep
10. Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies
11. Tunitas Therapeutics Awarded Phase II SBIR Grant to Advance Asthma Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)... Mass. , Jan. 14, 2014 HeartWare ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that it expects revenues for the fourth ... expected full-year 2013 revenues to approximately $208 million. ...
(Date:1/14/2014)... N.J. , Jan. 14, 2014 InformEx, ... and sellers of high-value chemistry, will hold the 30 th ... Miami Beach Convention Center from January 21-24. ... 3,500 attendees from top pharmaceutical, fine chemical and specialty chemical ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
(Date:4/17/2014)... PLOS Pathogens , children who live in regions of ... immune response to infection with malaria parasites that may ... and illness and partially control the growth of malaria ... develop future interventions that prevent or mitigate the disease ... 200 million cases of malaria occur worldwide, resulting in ...
(Date:4/17/2014)... Two recent papers by a University of Colorado ... scientists develop treatments or vaccines for Dengue fever, ... other disease-causing flaviviruses. , Jeffrey S. Kieft, PhD, ... the School of Medicine and an early career ... colleagues recently published articles in the scholarly journals ...
(Date:4/17/2014)... biology team has created a new technology for ... could travel the body and selectively target cancer ... biological devices that monitor and modify human physiology ... However, no existing technology enabled bioengineers to build ... and respond in a customized fashion. , "The ...
(Date:4/17/2014)... estimated that as many as 10 million older Americans ... loneliness and isolation. , However, new research a ... older Americans for six years found that Internet ... depression by more than 30 percent. , "That,s a ... University professor of telecommunication, information studies and media who ...
(Date:4/17/2014)... 17, 2014 By discovering a new mechanism that ... stroke, researchers at UC Irvine and the Salk Institute ... limit or prevent stroke-induced brain damage. , A complex ... of death and primary reason for disability in the ... stroke and lets blood-borne material into the brain, causing ...
Breaking Medicine News(10 mins):Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2Health News:Internet use can help ward off depression among elderly 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2
... It was reported on the 30th May that one adult and ... Authorities of NHS Lanarkshire issued a statement confirming that there have ... Law, in South Lanarkshire. All of these cases have a link ... NHS announced that as there was no conclusive evidence yet that ...
... are significantly more likely to experience difficulties during childbirth //and ... of the gruesome practice, a new United Nations study has ... evidence of the harmful effects for women and children, calls ... women worldwide., ,The serious complications during childbirth it cites ...
... day after he was admitted in a private hospital here ... leader Pramod Mahajan // , today showed signs of improvement ... definite improvement in his conditon. His oxygen level and blood ... Rahul was admitted yesterday in the wee hours., ,The ...
... has provided succour to a couple by facilitating kidney donation ... produce a marriage certificate as required by the hospital//. ... Bombay Hospital to relax its rules and allow Chandrabhan Rangari ... ,Chandrabhan could not donate an organ to Sushila, ...
... Fertilisers and Steel Ramvilas Paswan announced that central government ... in order to promote and encourage studies and research ... that his ministry would set up four new institutes ... Education and Research (NIPER) in Hajipur in Bihar, Kolkata ...
... and more Indian students in Qatar, especially Doha, are ... secondary examinations//. ,After clearing their Central Board of ... making a beeline for the various distance education programmes ... ,The Indira Gandhi National Open University ...
Cached Medicine News:Health News:Diagnosis On a Fourth Patient Confirmed To Be E.Coli 2Health News:Indian Students in Qatar Opts For Distance Education 2
Used to establish and maintain nephrostomy drainage following pyeloplasty. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; stent must not r...
... urinary diversion and drainage. The stylet is ... sheath is left in place to ease ... the access sheath is removed and discarded. ... for external catheter retention. Supplied sterile in ...
... for percutaneous placement of a ... pelvis for nephrostomy drainage in ... sterile in peel-open packages. Intended ... evaluation is advised; catheter must ...
... contains primers, a FAM-labeled probe and an Alexa ... 115 bp region of the 5' UTR. This ... Alexa 532 and Texas Red reporter dyes like ... Reagent* (ASR) program is comprised of a series ...
Medicine Products: